Biora Therapeutics undertakes Chapter 11 sale process to position business for future growth.

Learn more
Biora Therapeutics Home
Activate the mobile navigation

Publications

Evaluation of novel lab-in-a-capsule technology for SIBO diagnosis
#SIBO & Microbiome
SIBO diagnosis: clinical survey of practice patterns, unmet needs, and perception of a novel ingestible diagnostic capsule
#SIBO & Microbiome
Targeted topical anti-α4β7 integrin antibody results in reduced accumulation of α4β7 memory T-cells in gut tissue in DSS-induced colitis mice
#NaviCap Targeted Therapeutic Delivery
Characterization of the bacterial makeup and quantitative distribution in patients with suspected small intestine bacterial overgrowth (SIBO): A meta-analysis
#SIBO & Microbiome
Accuracy of glucose breath testing for small intestine bacterial overgrowth (SIBO) using endoscopy aspirate cultures as a reference standard: A meta-analysis
#SIBO & Microbiome
Development of a swallowable diagnostic capsule to monitor gastrointestinal health
#SIBO & Microbiome
Development of targeted therapeutic antibodies for the treatment of inflammatory bowel disease: A proof of concept
#SIBO & Microbiome
A comparison of systemic versus targeted anti-TNFα antibody in treatment of colitis induced by adoptive transfer of CD44-/CD62L+ T-cells into RAG2-/- mice recipients
#SIBO & Microbiome